Group One Trading’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$135K Sell
46,900
-16,300
-26% -$64.2K ﹤0.01% 4450
2025
Q4
$257K Buy
63,200
+8,800
+16% +$39.4K ﹤0.01% 4141
2025
Q3
$193K Buy
54,400
+37,700
+226% +$136K ﹤0.01% 4701
2025
Q2
$45.6K Sell
16,700
-19,300
-54% -$39.8K ﹤0.01% 5651
2025
Q1
$60.5K Buy
36,000
+30,000
+500% +$83.9K ﹤0.01% 5007
2024
Q4
$9.78K Sell
6,000
-51,000
-89% -$152K ﹤0.01% 6106
2024
Q3
$237K Buy
57,000
+42,100
+283% +$221K ﹤0.01% 3462
2024
Q2
$81.4K Sell
14,900
-16,600
-53% -$132K ﹤0.01% 4127
2024
Q1
$315K Buy
31,500
+600
+2% +$4.5K ﹤0.01% 3174
2023
Q4
$126K Buy
30,900
+15,800
+105% +$58.2K ﹤0.01% 4261
2023
Q3
$58.4K Buy
+15,100
New +$81.2K ﹤0.01% 4949
2022
Q3
Sell
-1,000
Closed -$6K 8152
2022
Q2
$6K Buy
+1,000
New +$6.37K ﹤0.01% 7028
2021
Q4
Sell
-200
Closed -$5K 8773
2021
Q3
$5K Buy
+200
New +$4.2K ﹤0.01% 7755

Other funds holding SANA

Group One Trading's SANA Position: Q1 2026 in Review

Group One Trading increased its Sana Biotechnology (SANA) stake by 199% in Q1 2026, buying an estimated $293K and bringing the position to 111,917 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #3737.

Group One Trading first reported a position in SANA in Q3 2021 and has held it in 12 quarters since. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Group One Trading held 111,917 shares of Sana Biotechnology worth $322K as of Q1 2026.
  • Group One Trading bought 74,473 Sana Biotechnology shares in Q1 2026, an estimated $293K.
  • Sana Biotechnology made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3737 holding.
  • Group One Trading first reported a position in Sana Biotechnology in Q3 2021 and has held it in 12 quarters since.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.